SCHEMBL13699701

SCHEMBL13699701

NC(=O)c1oc2cc([N+](=O)[O-])ccc2c1NC(=O)c1cccc(F)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.53
HSD17B10 Q99714 3/20 0.53
TP53 P04637 3/20 0.53
TSHR P16473 2/20 0.53
MAPK10 P53779 2/20 0.53
AHR P35869 1/20 0.53
ALDH1A1 P00352 4/20 0.51
MEN1 O00255 8/20 0.50
KMT2A Q03164 8/20 0.50
HPGD P15428 2/20 0.50
NPSR1 Q6W5P4 2/20 0.50
GPR17 Q13304 2/20 0.45
P2RY2 P41231 1/20 0.45
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
HTT P42858 2/20 0.44
LMNA P02545 2/20 0.44
KDM4E B2RXH2 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
TDP1 Q9NUW8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13699863 0.83 MAPT (0.57) MAPTHSD17B10TP53TSHRMAPK10
SCHEMBL13699693 0.83 TP53 (0.57) MAPTHSD17B10TP53TSHRMAPK10
SCHEMBL4257150 0.80 TSHR (0.70) MAPTHSD17B10TP53TSHRMAPK10
SCHEMBL13699699 0.80 TP53 (0.65) MAPTHSD17B10TP53TSHRMAPK10
SCHEMBL13699870 0.80 MAPT (0.53) MAPTHSD17B10TP53TSHRMAPK10
SCHEMBL13699874 0.79 MAPT (0.60) MAPTHSD17B10TP53TSHRMAPK10
SCHEMBL13699707 0.79 SMN1; SMN2 (0.55) MAPTHSD17B10TP53TSHRMAPK10
SCHEMBL13699695 0.77 MAPT (0.57) MAPTHSD17B10TP53TSHRMAPK10
SCHEMBL13699700 0.77 MAPT (0.77) MAPTHSD17B10TP53TSHRMAPK10
SCHEMBL13699894 0.76 MAPT (0.56) MAPTHSD17B10TP53TSHRMAPK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE ADORA2A, ADORA2B, HTR1F MAPT 4025/4885HSD17B10 1250/4885TP53 4721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.